Published in Int J Radiat Oncol Biol Phys on February 01, 1988
Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report. J Med Case Rep (2009) 0.86
Angle-dependent ultrasonic detection and imaging of brachytherapy seeds using singular spectrum analysis. J Acoust Soc Am (2008) 0.86
Advances in brachytherapy. Rev Urol (2004) 0.85
Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiography. Radiol Case Rep (2016) 0.75
Pupil evaluation in addition to Glasgow Coma Scale components in prediction of traumatic brain injury and mortality. Br J Surg (2012) 1.73
[Three-dimensional radiation planning. Studies on clinical integration]. Strahlenther Onkol (1993) 1.69
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol (1998) 1.49
Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys (1999) 1.44
Additive effects of cisplatin and radiation in human tumor cells under oxic conditions. Radiother Oncol (1992) 1.44
[Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study]. HNO (2002) 1.41
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Ann Oncol (1997) 1.39
[Multisegmental electron irradiation of the thoracic wall following ablative therapy of breast cancer]. Strahlenther Onkol (1994) 1.39
[Stereotactic convergent-beam irradiation: its current prospects based on clinical results]. Strahlenther Onkol (1992) 1.39
Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol (2001) 1.30
High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol (2001) 1.28
Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys (2000) 1.28
Relatedness among coagulase-negative staphylococci: deoxyribonucleic acid reassociation and comparative immunological studies. Arch Microbiol (1979) 1.25
The treatment of intertrochanteric fractures: results using an intramedullary nail with integrated cephalocervical screws and linear compression. J Orthop Trauma (2009) 1.25
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood (1994) 1.13
Control of cavitation activity by different shockwave pulsing regimes. Phys Med Biol (1999) 1.07
Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys (2001) 1.05
Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer (2001) 1.01
Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.00
Data security and protection in cross-institutional electronic patient records. Int J Med Inform (2003) 0.99
Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys (2000) 0.99
Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol (2001) 0.99
Stereotactic single high dose radiation therapy of benign intracranial meningiomas. Int J Radiat Oncol Biol Phys (1990) 0.98
Treatment of primary squamous cell carcinoma of the trachea: the role of radiation therapy. Radiother Oncol (1994) 0.98
Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys (1998) 0.98
Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys (1994) 0.97
Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys (2000) 0.97
Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys (2003) 0.95
Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys (2000) 0.95
Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences. Int J Radiat Oncol Biol Phys (2001) 0.94
Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma. Radiother Oncol (1998) 0.94
Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol (1999) 0.94
Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys (2001) 0.94
A comparative immunological study of catalases from coagulase-positive staphylococci. Arch Microbiol (1979) 0.91
Treatment of primary tracheal carcinoma. The role of external and endoluminal radiotherapy. Strahlenther Onkol (2000) 0.91
Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiat Res (1998) 0.90
Correlation of intraoperatively irradiated volume and fibrosis in patients with soft-tissue sarcoma of the extremities. Int J Radiat Oncol Biol Phys (2001) 0.90
Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy. Cancer Res (1999) 0.90
Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol (1996) 0.90
Stereotactic radiation therapy for malignant choroidal tumors: preliminary, short-term results. Ophthalmology (2000) 0.89
Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series. J Bone Joint Surg Br (2011) 0.88
Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer. Semin Surg Oncol (2001) 0.88
[Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives]. Strahlenther Onkol (2000) 0.88
Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol (2004) 0.88
Surgical treatment of severe congenital thoracolumbar kyphosis through a single posterior approach. Bone Joint J (2013) 0.88
Influence of extracorporeal irradiation on the reintegration of autologous grafts of bone and joint. Study in a canine model. J Bone Joint Surg Br (2000) 0.87
[Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy]. Strahlenther Onkol (1987) 0.87
Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys (2000) 0.86
Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys (1996) 0.86
PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy. Radiother Oncol (1997) 0.85
Conservative treatment of breast cancer: modified irradiation technique for women with large breasts. Radiother Oncol (1994) 0.85
Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy. Radiother Oncol (1994) 0.85
External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys (1995) 0.85
Fractionated stereotactically guided radiotherapy of head and neck tumors: a report on clinical use of a new system in 195 cases. Radiother Oncol (1993) 0.85
A modified computer-assisted colorimetric microtitre assay (MTT) to assess in vitro radiosensitivity of V79, CaSki, HeLa and WiDr cells. Int J Radiat Biol (1994) 0.84
[Intraoperative extracorporeal irradiation and replantation in local treatment of primary malignant bone tumors]. Orthopade (2003) 0.84
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma. Leukemia (1996) 0.84
Cement augmentation of the proximal femoral nail antirotation for the treatment of osteoporotic pertrochanteric fractures--a biomechanical cadaver study. Injury (2013) 0.84
The role of high-dose, single-fraction irradiation in small and large intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys (1994) 0.84
Conformal radiotherapy of challenging paraspinal tumors using a multiple arc segment technique. Int J Radiat Oncol Biol Phys (2000) 0.84
A new applicator, positionable to the center of tracheobronchial lumen for HDR-IR-192-afterloading of tracheobronchial tumors. Int J Radiat Oncol Biol Phys (1991) 0.84
Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI). Int J Radiat Oncol Biol Phys (2000) 0.83
[Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma]. Pneumologie (1996) 0.83
[Image-oriented planning of minimally invasive conformal irradiation of the head-neck area]. Radiologe (1996) 0.82
[Stereotactic one-time irradiation (radiosurgery). The methods, indications and results]. Strahlenther Onkol (1999) 0.82
Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors. Semin Surg Oncol (2001) 0.81
[Simple bone cysts of the calcaneus. Differential diagnosis and therapy]. Unfallchirurg (2004) 0.81
Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls. Biol Psychiatry (1989) 0.80
Comparative immunological study of catalases in the genus Micrococcus. Arch Microbiol (1977) 0.80
Networking in shared care--first steps towards a shared electronic patient record for cancer patients. Methods Inf Med (2002) 0.80
Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors. Radiother Oncol (2000) 0.80
Assessment of neuropsychological changes in patients with arteriovenous malformation (AVM) after radiosurgery. Int J Radiat Oncol Biol Phys (1998) 0.80
Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol (1992) 0.80
Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys (1992) 0.80
[Magnetic resonance-guided therapy with focused ultrasound. Non-invasive surgery of breast carcinoma?]. Radiologe (2001) 0.80
[Improved tumor contrast and delineation in the stereotactic radiotherapy planning of cerebral gliomas and metastases with contrast media-supported FLAIR imaging]. Strahlenther Onkol (2000) 0.79
[Clinical and experimental studies on radiotherapy of inoperable tumors following partial synchronization]. Strahlentherapie (1974) 0.79
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group. Ann Oncol (1994) 0.79
Treatment planning intercomparison for spinal chordomas using intensity-modulated photon radiation therapy (IMRT) and carbon ions. Phys Med Biol (2003) 0.79
Target volume definition in radiation therapy. Br J Radiol (1997) 0.79
IORT for locally advanced or recurrent renal cell carcinoma. Front Radiat Ther Oncol (1997) 0.79
[Reirradiation of chest wall local recurrences from breast cancer]. Zentralbl Gynakol (2004) 0.79
[The value of radiotherapy for liver metastases]. Strahlenther Onkol (1993) 0.79
[Pulmonary reaction to radiation following mantle-field irradiation. Comparison of follow-up by conventional x-ray and by computed tomography]. Radiologe (1988) 0.79
Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer (1993) 0.79
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy. Recent Results Cancer Res (1998) 0.78
Intraoperative radiotherapy as adjuvant treatment for stage II/III rectal carcinoma. Recent Results Cancer Res (1998) 0.78
[Radiation sensitivity of the normal bile duct during high dose rate afterloading irradiation with Iridium 192. Experimental studies in pigs]. Strahlenther Onkol (1993) 0.78
[Late radiation changes after small volume radiosurgery of the rat brain. Measuring local cerebral blood flow and histopathological studies]. Strahlenther Onkol (2001) 0.78
Integration of coronal magnetic resonance imaging (MRI) into radiation treatment planning of mediastinal tumors. Strahlenther Onkol (1993) 0.78
IORT as adjuvant treatment in primary rectal carcinomas: multi-modality treatment. Front Radiat Ther Oncol (1997) 0.78
[The belly-board technic for the sparing of the small intestine. Studies on positioning accuracy taking into consideration conformational irradiation technics]. Strahlenther Onkol (1995) 0.78
[Intraoperative radiotherapy within the treatment concept of retroperitoneal soft tissue sarcomas]. Chirurg (1995) 0.78
[A rare nasopharyngeal tumor: Hodgkin's disease]. Laryngol Rhinol Otol (Stuttg) (1988) 0.78
[Value of local radiotherapy in treatment of osseous metastases, pathological fractures and spinal cord compression]. Radiologe (1995) 0.78
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer. Eur J Cancer (1997) 0.78
Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol (2000) 0.78
Interstitial radiotherapy with 198Au seeds in the primary management of carcinoma of the oral tongue: results in Freiburg/Breisgau from January 1964 to July 1980. Int J Radiat Oncol Biol Phys (1982) 0.78
Radiation recall dermatitis from docetaxel. Onkologie (2002) 0.78
Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngenic rat prostate tumour model. Int J Radiat Biol (2002) 0.78